Variant report
Variant | nsv968213 |
---|---|
Chromosome Location | chr5:79794173-79797743 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:79794642-79794711 | Lung_OC | lung: | n/a | n/a |
2 | POLR2A | chr5:79794299-79794474 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | POLR2A | chr5:79794968-79795369 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | REST | chr5:79796957-79797141 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | REST | chr5:79796916-79797193 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | RFX5 | chr5:79795481-79795660 | K562 | blood: | n/a | n/a |
7 | STAT3 | chr5:79797212-79797421 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:79791201..79794183-chr5:79803550..79806446,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
FAM151B | TF binding region |
ENSG00000242706 | TF binding region |
RPL7P24 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560316161 | chr5:79794219-79794220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563795956 | chr5:79794225-79794226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371560826 | chr5:79794249-79794250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532556575 | chr5:79794299-79794300 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs78637481 | chr5:79794344-79794345 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs569421407 | chr5:79794357-79794358 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs73769115 | chr5:79794457-79794458 | Enhancers Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs576352867 | chr5:79794463-79794464 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs548634012 | chr5:79794487-79794488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114564132 | chr5:79794490-79794491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370365813 | chr5:79794617-79794618 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534339364 | chr5:79794635-79794636 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554262913 | chr5:79794678-79794679 | Enhancers Weak transcription ZNF genes & repeats | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs570638686 | chr5:79794684-79794685 | Enhancers Weak transcription ZNF genes & repeats | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs539226638 | chr5:79794690-79794691 | Enhancers Weak transcription ZNF genes & repeats | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs115170118 | chr5:79794723-79794724 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148061654 | chr5:79794733-79794734 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541707799 | chr5:79794774-79794775 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533163195 | chr5:79794784-79794785 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550182728 | chr5:79794789-79794790 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111303160 | chr5:79794804-79794805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201109845 | chr5:79794833-79794834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540735875 | chr5:79794846-79794847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145813328 | chr5:79794873-79794874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532762052 | chr5:79794913-79794914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546105849 | chr5:79794920-79794921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563079940 | chr5:79794924-79794925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372661181 | chr5:79794941-79794942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531951358 | chr5:79794950-79794951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548894587 | chr5:79794963-79794964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376888009 | chr5:79794977-79794978 | Weak transcription Enhancers | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs369212951 | chr5:79795064-79795065 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs576337132 | chr5:79795084-79795085 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs183874509 | chr5:79795102-79795103 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs547930012 | chr5:79795111-79795112 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs570831546 | chr5:79795129-79795130 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs138638639 | chr5:79795151-79795152 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs142765466 | chr5:79795184-79795185 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs569824759 | chr5:79795203-79795204 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs75749233 | chr5:79795208-79795209 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs555200552 | chr5:79795233-79795234 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs189229170 | chr5:79795239-79795240 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs537568627 | chr5:79795264-79795265 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs534292146 | chr5:79795267-79795268 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs79871521 | chr5:79795407-79795408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116647661 | chr5:79795413-79795414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543491948 | chr5:79795455-79795456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74441502 | chr5:79795487-79795488 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs11952983 | chr5:79795488-79795489 | Weak transcription | TF binding region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs191407955 | chr5:79795490-79795491 | Weak transcription | TF binding region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:79784600-79794600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:79784600-79797400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr5:79784800-79806600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr5:79784800-79819400 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
5 | chr5:79785000-79822800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:79785200-79817600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr5:79787600-79795000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
8 | chr5:79790800-79794600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr5:79790800-79811200 | Weak transcription | Placenta | Placenta |
10 | chr5:79791000-79794400 | Weak transcription | H1 Cell Line | embryonic stem cell |
11 | chr5:79791400-79794400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
12 | chr5:79791400-79798000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
13 | chr5:79793600-79794600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
14 | chr5:79794400-79794800 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr5:79794400-79794800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
16 | chr5:79794600-79794800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr5:79794600-79794800 | ZNF genes & repeats | Esophagus | oesophagus |
18 | chr5:79794600-79795000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr5:79794600-79795000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr5:79794800-79798000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
21 | chr5:79794800-79812800 | Weak transcription | Esophagus | oesophagus |
22 | chr5:79795000-79797600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
23 | chr5:79795600-79806000 | Weak transcription | Psoas Muscle | Psoas |
24 | chr5:79797600-79799000 | Enhancers | Primary neutrophils fromperipheralblood | blood |